{"url_path":"/sec/revb/8-k/2026-07-13/item-5-03","section_key":"item-5-03","section_title":"Item 5.03 Amendments to Articles of Incorporation or Bylaws, Change in Fiscal Year.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-13","source_url":"https://www.sec.gov/Archives/edgar/data/1810560/0001193125-26-302008-index.html","accession_number":"0001193125-26-302008","cik":"0001810560","ticker":"REVB","issuer_name":"REVELATION BIOSCIENCES, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1810560/0001193125-26-302008-index.html","primary_entity_key":"0001810560","primary_entity_name":"REVELATION BIOSCIENCES, INC."},"word_count":86,"has_tables":true,"body_markdown":"Item 5.03 Amendments to Articles of Incorporation or Bylaws, Change in Fiscal Year.\n\nIn connection with the adoption of the Rights Agreement, on July 9, 2026 the Company filed a Certificate of Designation of Series B Junior Participating Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware, establishing the rights, preferences, and privileges of the Preferred Stock issuable upon exercise of the Rights. The Certificate of Designation is filed as Exhibit 3.1 hereto and is incorporated herein by reference."}